Pharmaceutical executive Taggart McGurrin joins Life Sciences 360 podcast to discuss innovations in pain management
Senior pharmaceutical industry executive Taggart McGurrin recently appeared on the Life Sciences 360 podcast to share his innovative ideas and industry insights in the field of non-addictive pain management.
Tagg McGurrin, a pioneering executive in pharmaceutical innovation, recently appeared as a special guest on the Life Sciences 360 podcast. The show is a leading program in the life sciences industry, focusing on industry trends. During the episode,McGurrinshared his insights on revolutionizing pain management and creating responsible alternatives to opioids.
Combining personal experience withexpertise, McGurrin articulated his mission to develop non-addictive pain management solutions. The conversation covered the challenges faced by high-growth pharmaceutical startups and the importance of prioritizing patient well-being in drug development.
"We are working to achieve pain management without depriving people of their cognitive abilities," McGurrin shared on the show. "The key is helping people return to the things they love and need to do, so they can feel fulfilled in life."
Full EpisodeNow available on all major podcast platforms.
Taggart "Tagg" McGurrinis a distinguished pharmaceutical executive with multidisciplinary expertise spanning finance, law, and biotechnology. His unique skill set enables him to navigate the complex landscape of drug development and commercialization with precision and foresight. McGurrin's academic achievements include completing a dual bachelor's/MBA in accounting in four years, followed by earning his CPA certification while working at Bank of America. He further obtained a law degree from Temple University Beasley School of Law. Since entering the pharmaceutical industry in 2017, McGurrin has held several key leadership positions, including President, Chief Financial Officer, and Chief Operating Officer, focusing on driving biotech innovation and addressing critical medical challenges.
